documents: FDA-2022-N-2673-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2673-0001 FDA FDA-2022-N-2673 Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use; Request for Comments Notice Request for Comments 2022-11-16T05:00:00Z 2022 11 2022-11-16T05:00:00Z 2023-01-18T04:59:59Z 2023-01-19T02:00:34Z 2022-24874 0 0 09000064854bb10e

Links from other tables